Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/liver-transplantation-for-unresectable-neuroendocrine-tumor-liver-JH4TMgjrDD
References (50)
-
M. Vivarelli, A. Cucchetti, G. Barba, M. Ravaioli, M. Gaudio, A. Lauro, G. Grazi, A. Pinna (2008)
Liver Transplantation for Hepatocellular Carcinoma Under Calcineurin Inhibitors: Reassessment of Risk Factors for Tumor RecurrenceAnnals of Surgery, 248
-
G Rindi, R Arnold, FT Bosman (2010)
WHO classification of tumors of the digestive system -
J. Rosenau, M. Bahr, R. Wasielewski, M. Mengel, H. Schmidt, B. Nashan, H. Lang, J. Klempnauer, M. Manns, K. Boeker (2002)
Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors.Transplantation, 73 3
-
Florian Bösch, Christoph Auernhammer, Christine Spitzweg, Martin Angele (2019)
Gastroenteropancreatic Neuroendocrine TumoursGastroenterology For General Surgeons
-
A. Pascher, J. Klupp, P. Neuhaus (2005)
Endocrine tumours of the gastrointestinal tract. Transplantation in the management of metastatic endocrine tumours.Best practice & research. Clinical gastroenterology, 19 4
-
E. Gregoire, Y. Treut (2010)
Liver transplantation for primary or secondary endocrine tumorsTransplant International, 23
-
U. Maggi, D. Consonni, M. Manini, S. Gatti, F. Cuccaro, F. Donato, G. Conte, P. Bertazzi, G. Rossi (2013)
Early and Late De Novo Tumors after Liver Transplantation in Adults: The Late Onset of Bladder Tumors in MenPLoS ONE, 8
-
T. Lehnert (1998)
Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients.Transplantation, 66 10
-
E. Haddad, Vivian McAlister, E. Renouf, R. Malthaner, M. Kjaer, L. Gluud (2006)
Cyclosporin versus tacrolimus for liver transplanted patients.The Cochrane database of systematic reviews, 4
-
A. Frilling, M. Malágo, F. Weber, A. Paul, S. Nadalin, G. Sotiropoulos, V. Cicinnati, S. Beckebaum, A. Bockisch, J. Mueller‐Brand, M. Hofmann, K. Schmid, G. Gerken, C. Broelsch (2006)
Liver transplantation for patients with metastatic endocrine tumors: Single‐center experience with 15 patientsLiver Transplantation, 12
-
N. Thao, T. Nguyen, Theresa Harring, J. Goss, Christine 'mahony (2011)
Neuroendocrine Liver Metastases and Orthotopic Liver Transplantation: The US ExperienceInternational Journal of Hepatology, 2011
-
F. Vilsteren, E. Baskin-Bey, D. Nagorney, S. Sanderson, W. Kremers, C. Rosen, G. Gores, T. Hobday (2006)
Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survivalLiver Transplantation, 12
-
R. Perry, A. Vinik (1996)
Endocrine tumors of the gastrointestinal tract.Annual review of medicine, 47
-
S. Florman, B. Touré, L. Kim, G. Gondolesi, S. Roayaie, N. Krieger, T. Fishbein, S. Emre, Charles Miller, M. Schwartz (2003)
Liver transplantation for neuroendocrine tumorsJournal of Gastrointestinal Surgery, 8
-
Y. Treut, E. Gregoire, J. Klempnauer, J. Belghiti, E. Jouve, J. Lerut, D. Castaing, O. Soubrane, O. Boillot, G. Mantion, K. Homayounfar, M. Bustamante, D. Azoulay, P. Wolf, M. Krawczyk, A. Pascher, B. Suc, L. Chiche, J. Urbina, V. Mejzlík, M. Pascual, J. Lodge, S. Gruttadauria, F. Paye, F. Pruvot, S. Thorban, A. Foss, R. Adam (2013)
Liver Transplantation for Neuroendocrine Tumors in Europe—Results and Trends in Patient Selection: A 213-Case European Liver Transplant Registry StudyAnnals of Surgery, 257
-
S. Bacchetti, S. Bertozzi, A. Londero, A. Uzzau, E. Pasqual (2013)
Surgical Treatment and Survival in Patients with Liver Metastases from Neuroendocrine Tumors: A Meta-Analysis of Observational StudiesInternational Journal of Hepatology, 2013
-
Jian-Wen Cheng, Yinghong Shi, Jia Fan, Xiaowu Huang, S. Qiu, Yong-sheng Xiao, Z. Wang, Z. Dai, Zhao-You Tang, Jian Zhou (2011)
An immune function assay predicts post-transplant recurrence in patients with hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 137
-
M. Pavel, E. Baudin, A. Couvelard, E. Krenning, K. Öberg, T. Steinmüller, M. Anlauf, B. Wiedenmann, R. Salazar (2011)
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown PrimaryNeuroendocrinology, 95
-
A. Jain, V. Patil, J. Fung (2008)
Incidence of de novo cancer and lymphoproliferative disorders after liver transplantation in relation to age and duration of follow‐upLiver Transplantation, 14
-
E. Bonaccorsi-Riani, C. Apestegui, A. Jouret-Mourin, C. Sempoux, P. Goffette, O. Ciccarelli, I. Borbath, C. Hubert, J. Gigot, Z. Hassoun, J. Lerut (2010)
Liver transplantation and neuroendocrine tumors: lessons from a single centre experience and from the literature reviewTransplant International, 23
-
L Sher (2009)
Association between timing of resection of primary tumor in patients undergoing liver transplantation for metastatic neuroendocrine tumor and survivalAm J Transplant., 12
-
V. Mazzaferro, A. Pulvirenti, J. Coppa (2007)
Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation?Journal of hepatology, 47 4
-
F. Panzuto, S. Nasoni, M. Falconi, V. Corleto, G. Capurso, S. Cassetta, M. Fonzo, V. Tornatore, M. Milione, S. Angeletti, M. Cattaruzza, V. Ziparo, C. Bordi, P. Pederzoli, G. Fave (2005)
Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization.Endocrine-related cancer, 12 4
-
F. Åberg, E. Pukkala, K. Höckerstedt, R. Sankila, H. Isoniemi (2008)
Risk of malignant neoplasms after liver transplantation: A population‐based studyLiver Transplantation, 14
-
R. Kashyap, A. Jain, J. Reyes, A. Demetris, K. Elmagd, S. Dodson, W. Marsh, V. Madariaga, G. Mazariegos, D. Geller, C. Bonham, T. Cacciarelli, P. Fontes, T. Starzl, J. Fung (2001)
Causes of death after liver transplantation in 4000 consecutive patients: 2 to 19 year follow-up.Transplantation proceedings, 33 1-2
-
IM Modlin, K Oberg, DC Chung, RT Jensen, WW de Herder, RV Thakker (2008)
Gastroenteropancreatic neuroendocrine tumorsLancet Oncol., 9
-
C. Honoré, O. Detry, A. Roover, M. Meurisse, P. Honoré (2003)
Liver transplantation for metastatic colon adenocarcinoma: report of a case with 10 years of follow-up without recurrenceTransplant International, 16
-
V. Mazzaferro (2010)
Surgical approach to the treatment of liver metastases from neuroendocrine tumors: Hepatic resection and liver transplantationTumori, 96
-
E. Grossman, J. Millis (2010)
Liver transplantation for non–hepatocellular carcinoma malignancy: Indications, limitations, and analysis of the current literatureLiver Transplantation, 16
-
M. Olausson, S. Friman, G. Herlenius, C. Cahlin, O. Nilsson, S. Jansson, B. Wängberg, H. Ahlman (2007)
Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumorsLiver Transplantation, 13
-
K. Yao, M. Talamonti, A. Nemcek, P. Angelos, H. Chrisman, J. Skarda, A. Benson, Sambasiva Rao, R. Joehl (2001)
Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors.Surgery, 130 4
-
R. Gedaly, M. Daily, D. Davenport, P. McHugh, A. Koch, P. Angulo, J. Hundley (2011)
Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database.Archives of surgery, 146 8
-
K Urata, S Kawasaki (2001)
Liver transplantation for liver metastases of colorectal cancer [in Japanese]Nippon Geka Gakkai Zasshi, 102
-
W. Herder, V. Mazzaferro, L. Tavecchio, B. Wiedenmann (2010)
8. Multidisciplinary Approach for the Treatment of Neuroendocrine TumorsTumori Journal, 96
-
A. Kornberg, B. Küpper, A. Tannapfel, K. Katenkamp, K. Thrum, O. Habrecht, J. Wilberg (2010)
Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: clinical patterns and outcome variables.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 36 3
-
P. Tomassetti, D. Campana, L. Piscitelli, R. Casadei, D. Santini, Francesca Nori, A. Morselli-Labate, R. Pezzilli, R. Corinaldesi (2005)
Endocrine pancreatic tumors: factors correlated with survival.Annals of oncology : official journal of the European Society for Medical Oncology, 16 11
-
K. Urata, S. Kawasaki (2001)
[Liver transplantation for liver metastases of colorectal cancer].Nihon Geka Gakkai zasshi, 102 5
-
A. Frilling, J. Li, E. Malamutmann, K. Schmid, A. Bockisch, C. Broelsch (2009)
Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic diseaseBritish Journal of Surgery, 96
-
R. Warner (2005)
Enteroendocrine tumors other than carcinoid: a review of clinically significant advances.Gastroenterology, 128 6
-
M. Rodríguez-Perálvarez, E. Tsochatzis, M. Naveas, G. Pieri, Carmen García-Caparrós, J. O’Beirne, A. Poyato-González, Gustavo Ferrín-Sánchez, J. Montero-Álvarez, D. Patch, D. Thorburn, J. Briceño, M. Mata, A. Burroughs (2013)
Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma.Journal of hepatology, 59 6
-
Z. Máthé, E. Tagkalos, A. Paul, E. Molmenti, L. Kóbori, I. Fouzas, S. Beckebaum, G. Sotiropoulos (2011)
Liver Transplantation for Hepatic Metastases of Neuroendocrine Pancreatic Tumors: A Survival-Based AnalysisTransplantation, 91
-
Jatinder Pruthi, Katherine Medkiff, K. Esrason, J. Donovan, E. Yoshida, S. Erb, U. Steinbrecher, T. Fong (2001)
Analysis of causes of death in liver transplant recipients who survived more than 3 yearsLiver Transplantation, 7
-
P. Clavien, M. Lesurtel, P. Bossuyt, G. Gores, B. Langer, A. Perrier (2012)
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.The Lancet. Oncology, 13 1
-
H. Ahlman, S. Friman, C. Cahlin, O. Nilsson, S. Jansson, B. Wängberg, M. Olausson (2004)
Liver Transplantation for Treatment of Metastatic Neuroendocrine TumorsAnnals of the New York Academy of Sciences, 1014
-
J. Sarmiento, G. Heywood, J. Rubin, D. Ilstrup, D. Nagorney, F. Que (2003)
Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival.Journal of the American College of Surgeons, 197 1
-
Y. Treut, Emilie Gregoire, Jacques Belghiti, O. Boillot, O. Soubrane, Georges Mantion, D. Cherqui, D. Castaing, Philippe Ruszniewski, Philippe Wolf, François Paye, Ephrem Salamé, Fabrice Muscari, F. Pruvot, J. Baulieux (2008)
Predictors of Long‐Term Survival After Liver Transplantation for Metastatic Endocrine Tumors: An 85‐Case French Multicentric ReportAmerican Journal of Transplantation, 8
-
K. Watt, R. Pedersen, W. Kremers, J. Heimbach, Michael Charlton (2010)
Evolution of Causes and Risk Factors for Mortality Post‐Liver Transplant: Results of the NIDDK Long‐Term Follow‐Up StudyAmerican Journal of Transplantation, 10
-
J. Ramage, A. Ahmed, J. Ardill, N. Bax, D. Breen, M. Caplin, P. Corrie, J. Davar, A. Davies, V. Lewington, T. Meyer, J. Newell-Price, G. Poston, N. Reed, A. Rockall, W. Steward, R. Thakker, C. Toubanakis, J. Valle, C. Verbeke, A. Grossman (2005)
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)Gut, 61
-
Y. Treut, J. Delpero, B. Dousset, D. Cherqui, P. Ségol, G. Mantion, L. Hannoun, G. Benhamou, B. Launois, O. Boillot, J. Domergue, H. Bismuth (1997)
Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report.Annals of surgery, 225 4
-
W. Schoening, Niklas Buescher, S. Rademacher, A. Andreou, S. Kuehn, R. Neuhaus, O. Guckelberger, G. Puhl, D. Seehofer, P. Neuhaus (2013)
Twenty‐Year Longitudinal Follow‐Up After Orthotopic Liver Transplantation: A Single‐Center Experience of 313 Consecutive CasesAmerican Journal of Transplantation, 13
- Publisher
- Springer Journals
- Copyright
- Copyright © 2014 by Society of Surgical Oncology
- Subject
- Medicine & Public Health; Surgical Oncology; Oncology; Surgery
- ISSN
- 1068-9265
- eISSN
- 1534-4681
- DOI
- 10.1245/s10434-014-3523-y
- pmid
- 24562931
- Publisher site
- See Article on Publisher Site
Abstract
LT might be considered in carefully selected patients. The risk of tumor recurrence remains a significant clinical problem after LT, but data focused on immunosuppression issue are lacking, and there are no currently approved strategies for prevention of recurrence or follow-up protocols. Further studies are needed to define universally accepted inclusion criteria, reliable predictors of better outcome, and optimal timing for LT.
Journal
Annals of Surgical Oncology – Springer Journals
Published: Feb 22, 2014